3
Views
8
CrossRef citations to date
0
Altmetric
KIDNEY STONES

Kidney Stones

Current issues in diagnosis and therapy

Pages 124-133 | Published online: 07 Jul 2016

References

  • Recurrent renal calculi. Br Med J 1981: 282: 5
  • Stewart AF, Broadus AE. The regulation of renal calcium excretion: an approach to hypercalciuria Ann Rev Med 1981: 32: 457–73
  • Coe FL. Clinical stone disease. In: Coe FL. Brenner BM, Stein JH, et al. eds. Contemporary issues in nephrology. 5. Nephrolithiasis. New York: Longman (Churchill Livingstone). 1980: 1–12
  • Coe FL. Prevention of kidney stones. Am J Med 1981: 71(4): 514–6
  • Pak CY, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis. Am J Med 1980 69(1): 19–30
  • Matty RH. Nephrolithiasis. In: Rubenstein E. Federman D. eds. Scientific American medicine. VIII. Nephrology. New York: Sci Am Illus Lib. 1981: 1–7
  • Broaduft AE. Nephrolithiasis in primary hyperparathyroidism. In: Coe et al. eds.3 pp 59–85
  • Smith LH. Oxalate and urinary calculi. In: Zurukzoglu W. Papadimitriou M. Pyrpasopoulos M. et al. eds. Proceedings, eighth International Congress of Nephrology. Athens. 1981: 1179–85
  • Ringsdorf WM Jr, Cheraskin E. Nutritional aspects of urolithiasis. South Med J 1981: 74(1): 41–3
  • Smith LH. Enteric hyperoxaluria and other hyperoxalurlc states. In: Coe et al. eds.3 pp 136–64
  • O'Regan PF, Joekes AM. Primary hyperoxaluria. J R Soc Med 1980:73 (8): 541–4
  • Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. In: Coe et al. eds.3 pp 116–35
  • Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis. and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 1982: 307(4): 217
  • Smith LH, Van Den Berg CJ, Wilson DM. Nutrition and urolithiasis. N Engl J Med 1978: 298(2): 87–9
  • Pak CY, Sakhaee K, Crowther C, et al. Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med 1980: 93(1): 36–9
  • Van Reen R. Protein intake in bladder stone disease. In: Zurukzoglu et al. eds.8 pp 1169–74
  • Robertson WB, Peacock M. Animal protein Intake in renal stone disease. In: Zurukzoglu et al. eds.8 pp 1163–8
  • Halperin EC, Thier SO. Cystinuria In: Coe et al. eds.3 pp 208–30
  • Lemann J Jr. Idiopathic hypercalciuria. In: Coe et al, eds,3 pp 86–115
  • Thomas WC Jr. Use of phosphates in patients with calcereous renal calculi. Kidney Int 1978: 13(5): 390–6
  • Backman U, Danielson BG, Johanason G, et al. Treatment of recurrent calcium stone formation with cellulose phosphate. J Urol 1980: 123(1): 9–13
  • Brocks P, Dahl C, Wolf H, et al. Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet 1981: 2(8238): 124–5
  • Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria. hyperuricosuriau or no metabolic disorder. Ann Intern Med 1977: 87(4): 404–10
  • Yendt ER, Cohanim M. Prevention of calcium stones with thiazides. Kidney Int 1978: 13(5): 397–409
  • Maschio G. Tessitore N, D'Anselo A, et al. Prevention of calcium nephrolithiasis with low-dose thiazide, amlloride and allopurinol. Am J Med 1981: 71: 623–6
  • Pak CT, Peters P, Hurt G. et al. Is selective therapy of recurrent nephrolithiasis possible? Am J Med 1981: 71(4): 615–22
  • Chaussy C, Brendel W. Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet 1980; 2(8207): 1265–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.